HBSS

Matrixx Initiatives: A Critical Test of Crisis Management

Do you own Matrixx stock (Nasdaq - MTXX)?

I work with a law firm investigating reports of possible securities law violations by Matrixx Initiatives, Inc., the maker of Zicam.

In a letter to Matrixx, the FDA concluded certain Zicam products may pose serious risks to consumers.

When the letter was released, Matrixx stock plummeted from approximately $19 per share to less than $7 per share. Since December 2007, insiders have sold more than $2.7 million worth of Matrixx shares.

Learn more: hbsslaw.com/matrixx

KB Home F4Q08 (Qtr End 11/30/08) Earnings Call Transcript

o you own a KB Home? You may have overpaid!

I work with a law firm that’s launched an investigation into KB Home. Published reports indicate KB worked with Countrywide’s appraisers to artificially inflate the appraisal values given to new KB homes.

Under this alleged agreement KB Home receives higher profits from inflated home sales and homeowners suffer large losses and unknowingly pay inflated prices.

If you are now or ever were a KB homeowner please visit hbsslaw.com/kbhomes. You can share your story or learn more about the investigation. The lead attorney also penned a blog on the subject today – check out classactionlawtoday.com for his thoughts.